Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
14.19
+0.05 (0.35%)
At close: Dec 5, 2025, 4:00 PM EST
14.22
+0.03 (0.24%)
After-hours: Dec 5, 2025, 7:58 PM EST

Dr. Reddy's Laboratories Revenue

Dr. Reddy's Laboratories had revenue of 88.28B INR in the quarter ending September 30, 2025, with 9.83% growth. This brings the company's revenue in the last twelve months to 343.10B, up 14.13% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.

Revenue (ttm)
343.10B INR
Revenue Growth
+14.13%
P/S Ratio
3.06
Revenue / Employee
12,336,845 INR
Employees
27,811
Market Cap
11.79B USD

Revenue Chart

* This company reports financials in INR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020174.60B20.75B13.49%
Mar 31, 2019153.85B11.82B8.32%
Mar 31, 2018142.03B1.22B0.87%
Mar 31, 2017140.81B-13.90B-8.98%
Mar 31, 2016154.71B6.52B4.40%
Mar 31, 2015148.19B16.02B12.12%
Mar 31, 2014132.17B15.90B13.68%
Mar 31, 2013116.27B19.53B20.19%
Mar 31, 201296.74B22.04B29.51%
Mar 31, 201174.69B4.42B6.28%
Mar 31, 201070.28B836.00M1.20%
Mar 31, 200969.44B19.44B38.87%
Mar 31, 200850.01B-15.09B-23.18%
Mar 31, 200765.10B40.83B168.24%
Mar 31, 200624.27B4.75B24.32%
Mar 31, 200519.52B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings